162 related articles for article (PubMed ID: 184054)
1. Opiate antagonists and the modification of heroin self-administration behavior in man: an experimental study.
Altman JL; Meyer RE; Mirin SM; McNamee HB
Int J Addict; 1976; 11(3):485-99. PubMed ID: 184054
[TBL] [Abstract][Full Text] [Related]
2. Analysis and modification of opiate reinforcement.
Meyer RE; McNamee HB; Mirin SM; Altman JL
Int J Addict; 1976; 11(3):467-84. PubMed ID: 184053
[TBL] [Abstract][Full Text] [Related]
3. The clinical usefulness of narcotic antagonists: implications of behavioral research.
Meyer RE; Mirin SM; Altman JL
Am J Drug Alcohol Abuse; 1975; 2(3-4):417-32. PubMed ID: 179316
[No Abstract] [Full Text] [Related]
4. A behavioral paradigm for the evaluation of narcotic antagonists.
Meyer RE; Mirin SM; Altman JL; McNamee HB
Arch Gen Psychiatry; 1976 Mar; 33(3):371-7. PubMed ID: 944026
[TBL] [Abstract][Full Text] [Related]
5. Limitations of an extinction approach to narcotic antagonist treatment.
Meyer R; Randall R; Barrington C; Mirin S; Greenberg I
NIDA Res Monogr; 1976 Sep; (9):123-35. PubMed ID: 187940
[No Abstract] [Full Text] [Related]
6. Aftercare on narcotic antagonists: prospects and problems.
Rawlins M; Randall M
Int J Addict; 1976; 11(3):501-11. PubMed ID: 184055
[TBL] [Abstract][Full Text] [Related]
7. Methadone maintenance and narcotic blocking drugs.
Wikler A
Int J Addict; 1977 Oct; 12(7):851-6. PubMed ID: 201577
[TBL] [Abstract][Full Text] [Related]
8. [The combined use of scopolamine, naltrexone and naloxone as a rapid, safe and effective detoxification treatment for heroin addicts].
Yang G; Zhou W; Xu K
Zhonghua Yi Xue Za Zhi; 1999 Sep; 79(9):679-82. PubMed ID: 11715458
[TBL] [Abstract][Full Text] [Related]
9. Psychopathology, craving, and mood during heroin acquisition: an experimental study.
Mirin SM; Meyer RE; McNamee HB; McDougle M
Int J Addict; 1976; 11(3):525-44. PubMed ID: 965128
[TBL] [Abstract][Full Text] [Related]
10. Methadone maintenance and narcotic blocking drugs. Appendix.
Wikler A
Int J Addict; 1977 Oct; 12(7):869-81. PubMed ID: 338517
[TBL] [Abstract][Full Text] [Related]
11. Operant analysis of human heroin self-administration and the effects of naltrexone.
Mello NK; Mendelson JH; Kuehnle JC; Sellers MS
J Pharmacol Exp Ther; 1981 Jan; 216(1):45-54. PubMed ID: 7452507
[TBL] [Abstract][Full Text] [Related]
12. NIDA's naltrexone research program.
Julius D
NIDA Res Monogr; 1976 Sep; (9):5-11. PubMed ID: 187943
[No Abstract] [Full Text] [Related]
13. Management of relapse in naltrexone maintenance for heroin dependence.
Sullivan MA; Garawi F; Bisaga A; Comer SD; Carpenter K; Raby WN; Anen SJ; Brooks AC; Jiang H; Akerele E; Nunes EV
Drug Alcohol Depend; 2007 Dec; 91(2-3):289-92. PubMed ID: 17681716
[TBL] [Abstract][Full Text] [Related]
14. Treatment of heroin-dependent persons with antagonists: current status.
Renault PF
NIDA Res Monogr; 1981; 28():11-22. PubMed ID: 6791000
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists.
Arch Gen Psychiatry; 1978 Mar; 35(3):335-40. PubMed ID: 365122
[TBL] [Abstract][Full Text] [Related]
16. Depot naltrexone: antagonism of the reinforcing, subjective, and physiological effects of heroin.
Sullivan MA; Vosburg SK; Comer SD
Psychopharmacology (Berl); 2006 Nov; 189(1):37-46. PubMed ID: 16972105
[TBL] [Abstract][Full Text] [Related]
17. A comparison of antagonist-precipitated withdrawal under anesthesia to standard inpatient withdrawal as a precursor to maintenance naltrexone treatment in heroin users: outcomes at 6 and 12 months.
McGregor C; Ali R; White JM; Thomas P; Gowing L
Drug Alcohol Depend; 2002 Sep; 68(1):5-14. PubMed ID: 12167548
[TBL] [Abstract][Full Text] [Related]
18. Naltrexone implants can completely prevent early (1-month) relapse after opiate detoxification: a pilot study of two cohorts totalling 101 patients with a note on naltrexone blood levels.
Foster J; Brewer C; Steele T
Addict Biol; 2003 Jun; 8(2):211-7. PubMed ID: 12850780
[TBL] [Abstract][Full Text] [Related]
19. Predictors of retention in naltrexone maintenance for opioid dependence: analysis of a stage I trial.
Sullivan MA; Rothenberg JL; Vosburg SK; Church SH; Feldman SJ; Epstein EM; Kleber HD; Nunes EV
Am J Addict; 2006; 15(2):150-9. PubMed ID: 16595353
[TBL] [Abstract][Full Text] [Related]
20. Antagonist-precipitated heroin withdrawal under anaesthetic prior to maintenance naltrexone treatment: determinants of withdrawal severity.
Ali R; Thomas P; White J; McGregor C; Danz C; Gowing L; Stegink A; Athanasos P
Drug Alcohol Rev; 2003 Dec; 22(4):425-31. PubMed ID: 14660132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
